MedTrace Logo

Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy

NCT03509220 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2018-11-26

No results posted yet for this study

Summary

This study evaluates the efficacy, safety and tolerability of PBK-1701TC for bowel cleansing before colonoscopy. Half the participants will receive PBK-1701TC and while the other will receive standard oral preparation.

Conditions

  • Colonic Diseases
  • Intestinal Disease
  • Gastrointestinal Disease
  • Digestive System Disease

Interventions

DRUG

PBK-1701TC

The subject will receive PBK-1701TC for colonoscopy.

DRUG

Standard oral preparation

The subject will receive the standard oral preparation for colonoscopy

Sponsors & Collaborators

  • Pharmbio Korea Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509220 on ClinicalTrials.gov